MedPath

Research on the effectiveness of collagen tripeptide that target arterial sclerosis

Not Applicable
Conditions
Arteriosclerosis
Registration Number
JPRN-UMIN000023186
Lead Sponsor
Saiseikai Matsuyama Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1.Those who study doctor was ineligible as an object of the present study 2. Those of type 1 or type 2 diabetes 3. A person suspected of cerebral infarction with paralysis Four. Acute coronary syndrome, unstable angina, acute myocardial infarction, a person with a history of acute cerebral infarction and transient ischemic attack Five. Patients with cancer 6. Hypothyroidism, the person suspected of Graves' disease 7. A person suspected of liver disease, including hepatitis virus persistent infection 8. Persons with renal disease severe 9. A person who has a liver disorder of severe 10. Who during pregnancy and lactation 11. Patient in hospital 12. It is under ingestion other health supplements, functional foods, those who can not stop eating during the test

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath